Bringing the fundamentals into focus…
Back to NeuroOne Medical Technologies Corporation
How NeuroOne Medical Technologies Corporation stacks up
NMTC · against 8 other Healthcare companies of similar size
Valuation
8/ 100
Below the middle of the pack.
Ranked #5 of 9 · scores higher than 25% of peers
Bars: peers in each 10-point band of the valuation score5 peers with a valuation score of 0–9, including NMTC · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -99.0% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -100.9% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -80.3% vs peer median 0.0%
Metric by metric
Position: dot = NMTC, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NMTC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 7 reported | -99.0% | -251.7% | 83% | 30% | |
| EBITDA yieldHigher is better · 11 reported | -100.9% | -28.1% | 20% | 50% | |
| Free cash flow yieldHigher is better · 7 reported | -80.3% | -115.2% | 67% | 20% | |
| Book yieldHigher is better · 8 reported | 44.2% | 103.3% | 29% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around NMTC| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.3B KRW (≈$10M) | 71 | 53 | |
| 2 | 17M USD | 33 | 10 | |
| 3 | 21.3B KRW (≈$15M) | 30 | 28 | |
| 3 | 12M USD | 30 | 38 | |
| 5 | 17M USD | 8 | 16 | |
| 5 | 17M USD | 8 | 18 | |
| 5 | 9M USD | 8 | 45 | |
| 8 | 18M AUD (≈$12M) | 0 | 7 | |
| 8 | 22M AUD (≈$15M) | 0 | 25 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score